{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:40:08Z","timestamp":1789756808897,"version":"4.0.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["451-03-137\/2025-03\/200113"],"award-info":[{"award-number":["451-03-137\/2025-03\/200113"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["451-03-136\/2025-03\/200113"],"award-info":[{"award-number":["451-03-136\/2025-03\/200113"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s40261-026-01544-0","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T17:26:33Z","timestamp":1774718793000},"page":"517-530","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Urinary MicroRNA Expression and Tacrolimus Pharmacokinetic Variability in Kidney Transplant Recipients: A Cross-sectional Study"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2599-7508","authenticated-orcid":false,"given":"Nikola","family":"Stefanovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Dankovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radmila","family":"Veli\u010dkovi\u0107-Radovanovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Vukeli\u0107-Nikoli\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0161a","family":"Jovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stevan","family":"Vuji\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladana","family":"Stojiljkovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branka","family":"Miti\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Cvetkovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"issue":"10","key":"1544_CR1","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1111\/j.1600-6143.2011.03666.x.","volume":"11","author":"MJ Scian","year":"2011","unstructured":"Scian MJ, Maluf DG, David KG, Archer KJ, Suh JL, Wolen AR, et al. MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF\/TA. Am J Transplant. 2011;11(10):2110\u201322. https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03666.x.","journal-title":"Am J Transplant"},{"issue":"1","key":"1544_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2020.100591","volume":"35","author":"J Wu","year":"2021","unstructured":"Wu J, Zhang F, Zhang J, Sun Z, Wang W. Advances of miRNAs in kidney graft injury. Transplant Rev (Orlando). 2021;35(1):100591. https:\/\/doi.org\/10.1016\/j.trre.2020.100591.","journal-title":"Transplant Rev (Orlando)"},{"issue":"8","key":"1544_CR3","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/cbf.3555","volume":"38","author":"K Ramanathan","year":"2020","unstructured":"Ramanathan K, Padmanabhan G. MiRNAs as potential biomarker of kidney diseases: a review. Cell Biochem Funct. 2020;38(8):990\u20131005. https:\/\/doi.org\/10.1002\/cbf.3555.","journal-title":"Cell Biochem Funct"},{"key":"1544_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/978-3-319-22671-2_14","volume":"888","author":"K Jelencsics","year":"2015","unstructured":"Jelencsics K, Oberbauer R. microRNA and kidney transplantation. Adv Exp Med Biol. 2015;888:271\u201390. https:\/\/doi.org\/10.1007\/978-3-319-22671-2_14.","journal-title":"Adv Exp Med Biol"},{"issue":"11","key":"1544_CR5","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1097\/TP.0b013e3182751efd","volume":"94","author":"IZ Ben-Dov","year":"2012","unstructured":"Ben-Dov IZ, Muthukumar T, Morozov P, Mueller FB, Tuschl T, Suthanthiran M. MicroRNA sequence profiles of human kidney allografts with or without tubulointerstitial fibrosis. Transplantation. 2012;94(11):1086\u201394. https:\/\/doi.org\/10.1097\/TP.0b013e3182751efd.","journal-title":"Transplantation"},{"issue":"2","key":"1544_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/ki.2013.338","volume":"85","author":"DG Maluf","year":"2014","unstructured":"Maluf DG, Dumur CI, Suh JL, Scian MJ, King AL, Cathro H, et al. The urine microRNA profile may help monitor post-transplant renal graft function. Kidney Int. 2014;85(2):439\u201349. https:\/\/doi.org\/10.1038\/ki.2013.338.","journal-title":"Kidney Int"},{"issue":"9","key":"1544_CR7","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s11255-017-1602-2","volume":"49","author":"S Zununi Vahed","year":"2017","unstructured":"Zununi Vahed S, Poursadegh Zonouzi A, Ghanbarian H, Ghojazadeh M, Samadi N, Omidi Y, et al. Differential expression of circulating miR-21, miR-142-3p and miR-155 in renal transplant recipients with impaired graft function. Int Urol Nephrol. 2017;49(9):1681\u20139. https:\/\/doi.org\/10.1007\/s11255-017-1602-2.","journal-title":"Int Urol Nephrol"},{"issue":"11","key":"1544_CR8","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1111\/tri.12798.","volume":"29","author":"N Shuker","year":"2016","unstructured":"Shuker N, Shuker L, van Rosmalen J, Roodnat JI, Borra LC, Weimar W, et al. A high intrapatient variability in tacrolimus exposure is associated with poor long-term outcome of kidney transplantation. Transpl Int. 2016;29(11):1158\u201367. https:\/\/doi.org\/10.1111\/tri.12798.","journal-title":"Transpl Int"},{"issue":"6","key":"1544_CR9","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1097\/TP.0000000000002920.","volume":"104","author":"T Jouve","year":"2020","unstructured":"Jouve T, Fonrose X, Noble J, Janbon B, Fiard G, Malvezzi P, et al. The TOMATO Study (tacrolimus metabolization in kidney transplantation): impact of the concentration-dose ratio on death-censored graft survival. Transplantation. 2020;104(6):1263\u201371. https:\/\/doi.org\/10.1097\/TP.0000000000002920.","journal-title":"Transplantation"},{"issue":"2","key":"1544_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.trre.2015.01.002.","volume":"29","author":"N Shuker","year":"2015","unstructured":"Shuker N, van Gelder T, Hesselink DA. Intra-patient variability in tacrolimus exposure: causes, consequences for clinical management. Transplant Rev. 2015;29(2):78\u201384. https:\/\/doi.org\/10.1016\/j.trre.2015.01.002.","journal-title":"Transplant Rev"},{"issue":"9","key":"1544_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14091755","volume":"14","author":"M Brunet","year":"2022","unstructured":"Brunet M, Pastor-Anglada M. Insights into the pharmacogenetics of tacrolimus pharmacokinetics and pharmacodynamics. Pharmaceutics. 2022;14(9):1755. https:\/\/doi.org\/10.3390\/pharmaceutics14091755.","journal-title":"Pharmaceutics"},{"issue":"7","key":"1544_CR12","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.3390\/jcm9072193","volume":"9","author":"C Thongprayoon","year":"2020","unstructured":"Thongprayoon C, Hansrivijit P, Kovvuru K, Kanduri SR, Bathini T, Pivovarova A, et al. Impacts of high intra- and inter-individual variability in tacrolimus pharmacokinetics and fast tacrolimus metabolism on outcomes of solid organ transplant recipients. J Clin Med. 2020;9(7):2193. https:\/\/doi.org\/10.3390\/jcm9072193.","journal-title":"J Clin Med"},{"key":"1544_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01142","volume":"11","author":"T van Gelder","year":"2020","unstructured":"van Gelder T, Meziyerh S, Swen JJ, de Vries APJ, Moes DJAR. The clinical impact of the C0\/D ratio and the CYP3A5 genotype on outcome in tacrolimus treated kidney transplant recipients. Front Pharmacol. 2020;11:1142. https:\/\/doi.org\/10.3389\/fphar.2020.01142.","journal-title":"Front Pharmacol"},{"issue":"1-2","key":"1544_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.clinbiochem.2016.08.007","volume":"50","author":"S Zununi Vahed","year":"2017","unstructured":"Zununi Vahed S, Omidi Y, Ardalan M, Samadi N. Dysregulation of urinary miR-21 and miR-200b associated with Interstitial Fibrosis and Tubular Atrophy (IFTA) in renal transplant recipients. Clin Biochem. 2017;50(1\u20132):32\u20139. https:\/\/doi.org\/10.1016\/j.clinbiochem.2016.08.007.","journal-title":"Clin Biochem"},{"issue":"4","key":"1544_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","volume":"145","author":"AS Levey","year":"2006","unstructured":"Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247\u201354. https:\/\/doi.org\/10.7326\/0003-4819-145-4-200608150-00004.","journal-title":"Ann Intern Med"},{"issue":"2","key":"1544_CR16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.trre.2017.12.001","volume":"32","author":"N Janszky","year":"2018","unstructured":"Janszky N, S\u00fcsal C. Circulating and urinary microRNAs as possible biomarkers in kidney transplantation. Transplant Rev (Orlando). 2018;32(2):110\u20138. https:\/\/doi.org\/10.1016\/j.trre.2017.12.001.","journal-title":"Transplant Rev (Orlando)"},{"issue":"3","key":"1544_CR17","doi-asserted-by":"publisher","first-page":"270","DOI":"10.5937\/afmnai40-39805","volume":"40","author":"V Stojiljkovi\u0107","year":"2023","unstructured":"Stojiljkovi\u0107 V, Stefanovi\u0107 N, Vukeli\u0107 Nikoli\u0107 M, \u0110or\u0111evi\u0107 B, Ba\u0161i\u0107 J, Koci\u0107 G, et al. MicroRNA: potential biomarkers in chronic kidney disease. Acta Facultatis Medicae Naissensis. 2023;40(3):270\u20138. https:\/\/doi.org\/10.5937\/afmnai40-39805.","journal-title":"Acta Facultatis Medicae Naissensis."},{"issue":"2","key":"1544_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058014","volume":"8","author":"F Glowacki","year":"2013","unstructured":"Glowacki F, Savary G, Gnemmi V, Buob D, Van der Hauwaert C, Lo-Guidice J-M, et al. Increased circulating miR-21 levels are associated with kidney fibrosis. PLoS ONE. 2013;8(2):e58014. https:\/\/doi.org\/10.1371\/journal.pone.0058014.","journal-title":"PLoS ONE"},{"issue":"1","key":"1544_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-38642-3","volume":"9","author":"U Khalid","year":"2019","unstructured":"Khalid U, Newbury LJ, Simpson K, Jenkins RH, Bowen T, Bates L, et al. A urinary microRNA panel that is an early predictive biomarker of delayed graft function following kidney transplantation. Sci Rep. 2019;9(1):3584. https:\/\/doi.org\/10.1038\/s41598-019-38642-3.","journal-title":"Sci Rep"},{"issue":"2","key":"1544_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10020113","volume":"10","author":"MS Gniewkiewicz","year":"2020","unstructured":"Gniewkiewicz MS, Paszkowska I, Gozdowska J, Czerwinska K, Sadowska-Jakubowicz A, Deborska-Materkowska D, et al. Urinary MicroRNA-21-5p as potential biomarker of Interstitial Fibrosis and Tubular Atrophy (IFTA) in kidney transplant recipients. Diagnostics. 2020;10(2):113. https:\/\/doi.org\/10.3390\/diagnostics10020113.","journal-title":"Diagnostics"},{"issue":"1","key":"1544_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1476-511X-13-27","volume":"13","author":"J Feng","year":"2014","unstructured":"Feng J, Li A, Deng J, Yang Y, Dang L, Ye Y, et al. miR-21 attenuates lipopolysaccharide-induced lipid accumulation and inflammatory response: potential role in cerebrovascular disease. Lipids Health Dis. 2014;13(1):27. https:\/\/doi.org\/10.1186\/1476-511X-13-27.","journal-title":"Lipids Health Dis"},{"issue":"8","key":"1544_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042316","volume":"7","author":"N Dey","year":"2012","unstructured":"Dey N, Ghosh-Choudhury N, Kasinath BS, Choudhury GG. TGF\u03b2-stimulated microRNA-21 utilizes PTEN to orchestrate AKT\/mTORC1 signaling for mesangial cell hypertrophy and matrix expansion. PLoS ONE. 2012;7(8):e42316. https:\/\/doi.org\/10.1371\/journal.pone.0042316.","journal-title":"PLoS ONE"},{"issue":"2","key":"1544_CR23","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3892\/mmr.2014.2312","volume":"10","author":"L Lin","year":"2014","unstructured":"Lin L, Gan H, Zhang H, Tang W, Sun Y, Tang X, et al. MicroRNA 21 inhibits SMAD7 expression through a target sequence in the 3\u2019 untranslated region and inhibits proliferation of renal tubular epithelial cells. Mol Med Rep. 2014;10(2):707\u201312. https:\/\/doi.org\/10.3892\/mmr.2014.2312.","journal-title":"Mol Med Rep"},{"issue":"3","key":"1544_CR24","doi-asserted-by":"publisher","first-page":"940","DOI":"10.7150\/ijbs.97579","volume":"21","author":"Q Zhong","year":"2025","unstructured":"Zhong Q, Zeng J, Li Y, Zhang H, Lin T, Song T. Senescent renal tubular cells derived extracellular vesicles transported miR-20a and miR-21 induced macrophage-to-myofibroblast transition in renal fibrosis after ischemia reperfusion injury. Int J Biol Sci. 2025;21(3):940\u201354. https:\/\/doi.org\/10.7150\/ijbs.97579.","journal-title":"Int J Biol Sci"},{"issue":"7","key":"1544_CR25","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1681\/ASN.2016050573","volume":"28","author":"YY Wang","year":"2017","unstructured":"Wang YY, Jiang H, Pan J, Huang XR, Wang YC, Huang HF, et al. Macrophage-to-myofibroblast transition contributes to interstitial fibrosis in chronic renal allograft injury. J Am Soc Nephrol. 2017;28(7):2053\u201367. https:\/\/doi.org\/10.1681\/ASN.2016050573.","journal-title":"J Am Soc Nephrol"},{"issue":"20","key":"1544_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012253","volume":"23","author":"YJ Chen","year":"2022","unstructured":"Chen YJ, Hsu CT, Tsai SF, Chen CH. Association between circulating microRNAs (miR-21-5p, miR-20a-5p, miR-29b-3p, miR-126-3p and miR-101-3p) and chronic allograft dysfunction in renal transplant recipients. Int J Mol Sci. 2022;23(20):12253. https:\/\/doi.org\/10.3390\/ijms232012253.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1544_CR27","first-page":"615","volume":"14","author":"E Soltaninejad","year":"2015","unstructured":"Soltaninejad E, Nicknam MH, Nafar M, Sharbafi MH, Keshavarz Shahbaz S, Barabadi M, et al. Altered expression of microRNAs following chronic allograft dysfunction with interstitial fibrosis and tubular atrophy. Iran J Allergy Asthma Immunol. 2015;14(6):615\u201323.","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"1","key":"1544_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/cells13010084","volume":"13","author":"W Huang","year":"2023","unstructured":"Huang W, Paul D, Calin GA, Bayraktar R. miR-142: a master regulator in hematological malignancies and therapeutic opportunities. Cells. 2023;13(1):84. https:\/\/doi.org\/10.3390\/cells13010084.","journal-title":"Cells"},{"issue":"1","key":"1544_CR29","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.trim.2008.01.007","volume":"19","author":"W Sui","year":"2008","unstructured":"Sui W, Dai Y, Huang Y, Lan H, Yan Q, Huang H. Microarray analysis of microRNA expression in acute rejection after renal transplantation. Transpl Immunol. 2008;19(1):81\u20135. https:\/\/doi.org\/10.1016\/j.trim.2008.01.007.","journal-title":"Transpl Immunol"},{"issue":"2","key":"1544_CR30","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/embor.2008","volume":"10","author":"B Huang","year":"2009","unstructured":"Huang B, Zhao J, Lei Z, Shen S, Li D, Shen GX, et al. miR-142-3p restricts cAMP production in CD4+CD25- T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA. EMBO Rep. 2009;10(2):180\u20135. https:\/\/doi.org\/10.1038\/embor.2008.","journal-title":"EMBO Rep"},{"issue":"11","key":"1544_CR31","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.2215\/CJN.15590920","volume":"16","author":"E Langewisch","year":"2021","unstructured":"Langewisch E, Mannon RB. Chronic allograft injury. Clin J Am Soc Nephrol. 2021;16(11):1723\u20139. https:\/\/doi.org\/10.2215\/CJN.15590920.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"1544_CR32","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1681\/ASN.2011060543","volume":"23","author":"R Danger","year":"2012","unstructured":"Danger R, Pallier A, Giral M, Mart\u00ednez-Llordella M, Lozano JJ, Degauque N, et al. Upregulation of miR-142-3p in peripheral blood mononuclear cells of operationally tolerant patients with a renal transplant. J Am Soc Nephrol. 2012;23(4):597\u2013606. https:\/\/doi.org\/10.1681\/ASN.2011060543.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1544_CR33","doi-asserted-by":"publisher","first-page":"7303","DOI":"10.1080\/21655979.2022.2048771","volume":"13","author":"X Ge","year":"2022","unstructured":"Ge X, Sun Y, Tang Y, Lin J, Zhou F, Yao G, et al. Circular RNA HECTD1 knockdown inhibits transforming growth factor-beta\/ small mothers against decapentaplegic (TGF-\u03b2\/Smad) signaling to reduce hypertrophic scar fibrosis. Bioengineered. 2022;13(3):7303\u201315. https:\/\/doi.org\/10.1080\/21655979.2022.2048771.","journal-title":"Bioengineered"},{"key":"1544_CR34","doi-asserted-by":"publisher","first-page":"6263921","DOI":"10.1155\/2020\/6263921","volume":"2020","author":"W Zhang","year":"2020","unstructured":"Zhang W, Li X, Tang Y, Chen C, Jing R, Liu T. miR-155-5p implicates in the pathogenesis of renal fibrosis via targeting SOCS1 and SOCS6. Oxid Med Cell Longev. 2020;2020:6263921. https:\/\/doi.org\/10.1155\/2020\/6263921.","journal-title":"Oxid Med Cell Longev"},{"key":"1544_CR35","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1126\/science.1139253","volume":"316","author":"A Rodriguez","year":"2007","unstructured":"Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, et al. Requirement of bic\/microRNA-155 for normal immune function. Science. 2007;316:608\u201311. https:\/\/doi.org\/10.1126\/science.1139253.","journal-title":"Science"},{"issue":"7","key":"1544_CR36","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000001169","volume":"7","author":"EM Gielis","year":"2021","unstructured":"Gielis EM, Anholts JDH, van Beelen E, Haasnoot GW, De Fijter HW, Bajema I, et al. A combined microRNA and chemokine profile in urine to identify rejection after kidney transplantation. Transplant Direct. 2021;7(7):e711. https:\/\/doi.org\/10.1097\/TXD.0000000000001169.","journal-title":"Transplant Direct."},{"issue":"4","key":"1544_CR37","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1093\/nar\/gki200","volume":"33","author":"AM Cheng","year":"2005","unstructured":"Cheng AM, Byrom MW, Shelton J, Ford LP. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 2005;33(4):1290\u20137. https:\/\/doi.org\/10.1093\/nar\/gki200.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"1544_CR38","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.transproceed.2024.03.044","volume":"56","author":"R Nog","year":"2024","unstructured":"Nog R, Mopidevi B, Sivankutty I, Rivera VB, Islam HK, Glicklich D, et al. Polyomavirus microRNA in kidney transplant recipient. Transplant Proc. 2024;56(6):1493\u20135. https:\/\/doi.org\/10.1016\/j.transproceed.2024.03.044.","journal-title":"Transplant Proc"},{"issue":"6","key":"1544_CR39","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1159\/000339494","volume":"35","author":"K Kidokoro","year":"2012","unstructured":"Kidokoro K, Satoh M, Nagasu H, Sakuta T, Kuwabara A, Yorimitsu D, et al. Tacrolimus induces glomerular injury via endothelial dysfunction caused by reactive oxygen species and inflammatory change. Kidney Blood Press Res. 2012;35(6):549\u201357.","journal-title":"Kidney Blood Press Res"},{"key":"1544_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellsig.2018.08.013","volume":"52","author":"W Eberhardt","year":"2018","unstructured":"Eberhardt W, Nasrullah U, Pfeilschifter J. Activation of renal profibrotic TGF\u03b2 controlled signaling cascades by calcineurin and mTOR inhibitors. Cell Signal. 2018;52:1\u201311.","journal-title":"Cell Signal"},{"issue":"4","key":"1544_CR41","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/FTD.0b013e3181e06818","volume":"32","author":"DR Kuypers","year":"2010","unstructured":"Kuypers DR, Naesens M, de Jonge H, Lerut E, Verbeke K, Vanrenterghem Y. Tacrolimus dose requirements and CYP3A5 genotype and the development of calcineurin inhibitor-associated nephrotoxicity in renal allograft recipients. Ther Drug Monit. 2010;32(4):394\u2013404.","journal-title":"Ther Drug Monit"},{"key":"1544_CR42","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2147\/DMSO.S441082","volume":"17","author":"J Dong","year":"2024","unstructured":"Dong J, Liu M, Bian Y, Zhang W, Yuan C, Wang D, et al. MicroRNA-204-5p ameliorates renal injury via regulating Keap1\/Nrf2 pathway in diabetic kidney disease. Diabetes Metab Syndr Obes. 2024;17:75\u201392.","journal-title":"Diabetes Metab Syndr Obes."},{"issue":"7","key":"1544_CR43","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1681\/ASN.2019101100","volume":"31","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Wang D, Wang F, Liu J, Huang B, Baker MA, et al. Endogenous miR-204 protects the kidney against chronic injury in hypertension and diabetes. J Am Soc Nephrol. 2020;31(7):1539\u201354.","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"1544_CR44","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1111\/ajt.16002","volume":"20","author":"HM Gonzales","year":"2020","unstructured":"Gonzales HM, McGillicuddy JW, Rohan V, Chandler JL, Nadig SN, Dubay DA, et al. A comprehensive review of the impact of tacrolimus intrapatient variability on clinical outcomes in kidney transplantation. Am J Transplant. 2020;20(8):1969\u201383.","journal-title":"Am J Transplant"},{"issue":"1","key":"1544_CR45","doi-asserted-by":"publisher","first-page":"93","DOI":"10.5633\/amm.2019.0113","volume":"58","author":"N Stefanovi\u0107","year":"2019","unstructured":"Stefanovi\u0107 N, Veli\u010dkovi\u0107 Radovanovi\u0107 R, Cati\u0107 \u0110or\u0111evi\u0107 A, Damnjanovi\u0107 I, Dini\u0107 K, Miti\u0107 B, et al. Interindividual and intraindividual pharmacokinetic variability of tacrolimus within the first year after renal transplantation: effect of CYP3A5 gene polymorphism. Acta Med Medianae. 2019;58(1):93\u2013101. https:\/\/doi.org\/10.5633\/amm.2019.0113.","journal-title":"Acta Med Medianae"},{"key":"1544_CR46","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/FTD.0b013e31821a7aa3","volume":"33","author":"N Pashaee","year":"2011","unstructured":"Pashaee N, Bouamar R, Hesselink DA, et al. CYP3A5 genotype is not related to the intrapatient variability of tacrolimus clearance. Ther Drug Monit. 2011;33:369.","journal-title":"Ther Drug Monit"},{"issue":"22","key":"1544_CR47","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.2217\/epi-2020-0160","volume":"12","author":"RCC Freitas","year":"2020","unstructured":"Freitas RCC, Bortolin RH, Genvigir FDV, Bonezi V, Hirata TDC, Felipe CR, et al. Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study. Epigenomics. 2020;12(22):2019\u201334. https:\/\/doi.org\/10.2217\/epi-2020-0160.","journal-title":"Epigenomics"},{"issue":"12","key":"1544_CR48","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1111\/bcp.13399","volume":"83","author":"O Mill\u00e1n","year":"2017","unstructured":"Mill\u00e1n O, Budde K, Sommerer C, Aliart I, Rissling O, Bardaji B, et al. Urinary miR-155-5p and CXCL10 as prognostic and predictive biomarkers of rejection, graft outcome, and treatment response in kidney transplantation. Br J Clin Pharmacol. 2017;83(12):2636\u201350. https:\/\/doi.org\/10.1111\/bcp.13399.","journal-title":"Br J Clin Pharmacol"},{"issue":"16","key":"1544_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165592","volume":"21","author":"\u0160 Bor\u0161tnar","year":"2020","unstructured":"Bor\u0161tnar \u0160, Ve\u010deri\u0107-Haler \u017d, Bo\u0161tjan\u010di\u010d E, Pipan Tkalec \u017d, Kova\u010d D, Lindi\u010d J, et al. Uromodulin and microRNAs in kidney transplantation-association with kidney graft function. Int J Mol Sci. 2020;21(16):5592. https:\/\/doi.org\/10.3390\/ijms21165592.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1544_CR50","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/cpt.1618","volume":"107","author":"DRJ Kuypers","year":"2020","unstructured":"Kuypers DRJ. Intrapatient variability of tacrolimus exposure in solid organ transplantation: a novel marker for clinical outcome. Clin Pharmacol Ther. 2020;107(2):347\u201358. https:\/\/doi.org\/10.1002\/cpt.1618.","journal-title":"Clin Pharmacol Ther"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-026-01544-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-026-01544-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-026-01544-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T13:39:46Z","timestamp":1776865186000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-026-01544-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1544"],"URL":"https:\/\/doi.org\/10.1007\/s40261-026-01544-0","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures involving human participants were conducted in accordance with the ethical standards of the relevant institutional and\/or national research ethics committees, and with the Declaration of Helsinki and its later amendments or comparable ethical standards. The study was approved by the Ethics Committee of the University Clinical Center in Ni\u0161 (decision number: 4665\/11, dated 23 February 2022) and the Ethics Committee of the Faculty of Medicine, University of Ni\u0161 (approval number: 12-3588-2\/2, dated 07 April 2022).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed written consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The data presented in this study are available from the corresponding author upon reasonable request.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability Of Data And Material"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Conceptualization: Nikola Stefanovi\u0107 and Katarina Dankovi\u0107; Methodology: Nikola Stefanovi\u0107 and Marija Vukeli\u0107-Nikoli\u0107; Investigation: Katarina Dankovi\u0107, Ma\u0161a Jovi\u0107 and Vladana Stojiljkovi\u0107; Writing-review and editing: Nikola Stefanovi\u0107, Katarina Dankovi\u0107, Ma\u0161a Jovi\u0107, and Stevan Vuji\u0107; Supervision: Nikola Stefanovi\u0107, Radmila Veli\u010dkovi\u0107-Radovanovi\u0107, Branka Miti\u0107, and Tatjana Cvetkovi\u0107. All authors read and approved the final version and agree to be accountable for the work.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}